Clinical Roundup Phase III trial evaluating sotorasib + panitumumab: MCC patients with rare tumor mutation experienced superior PFS compared to standard of care November 03, 2023Vol.49 No.41
Clinical Roundup Phase III trial of Jemperli + chemo meets endpoint of OS in primary advanced or recurrent endometrial cancer November 03, 2023Vol.49 No.41
Clinical Roundup Report examines outcomes in children with Down syndrome and ALL November 03, 2023Vol.49 No.41
Clinical Roundup Identifying subtle differences in tumor cells can help treat endometrial cancer better November 03, 2023Vol.49 No.41
Clinical Roundup Researchers use DNA methylation and lifestyle data to estimate gastric cancer risk November 03, 2023Vol.49 No.41
Clinical Roundup “GPS” seed devices found effective in locating breast tumors in retrospective UC study November 03, 2023Vol.49 No.41
Clinical Roundup COVID-19 pandemic associated with decline in number of reported cancer cases October 27, 2023Vol.49 No.40
Clinical Roundup Phase III CheckMate-67T trial of subcutaneous Opdivo + hyaluronidase meets endpoints in advanced or metastatic ccRCC October 27, 2023Vol.49 No.40
Clinical Roundup Imfinzi + chemo more than doubled pathologic CRR in gastric, gastroesophageal junction cancers October 27, 2023Vol.49 No.40
Clinical Roundup DUO-E phase III trial: Imfinzi + Lynparza reduces risk of progression/death vs. chemo in advanced/recurrent endometrial cancer October 27, 2023Vol.49 No.40
